Sutro Biopharma, Inc.’s STRO share price has dipped by 35.19%, which has investors questioning if this is right time to buy.

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

Brand.com’s are connecting HCPs to information, with fewer hoops to jump through, courtesy of new digital tools promising to ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...

Smarter Heat Detection Activity monitoring technology is giving producers a more precise and efficient way to detect heats, ...

Data shows it can prevent six types of cancer. But anti-vaccine activists, including U.S. Health Secretary Robert F. Kennedy ...

By leveraging blockchain infrastructure and AI-powered content tools, $MERK seeks to redefine how memes are created, ...

The creation of the diagnostic accelerator AI4Leprosy and its proven efficacy provides proof of concept, paving the way for developing a mobile application to validate the tool further and ...

Whether you are a freelancer with a one-person business or in charge of multiple employees, there are many tools that can improve your operations. Let’s take a look at the best AI tools for business: ...